PILLAI, REGINAM.D. NPI 1720273121 Clinician
Pulmonary Disease · WEBSTER, TX
- CLEAR LAKE HOSPITALISTS PA — WEBSTER, TX
- CLS HEALTH PLLC — WEBSTER, TX
- HCA HOUSTON HEALTHCARE CLEAR LAKE · Hospital · CCN 450617
- HOUSTON METHODIST BAYTOWN HOSPITAL · Hospital · CCN 450424
- HOUSTON METHODIST CLEAR LAKE HOSPITAL · Hospital · CCN 450709
- MEMORIAL HERMANN HOSPITAL SYSTEM · Hospital · CCN 450184
- UNIVERSITY OF TEXAS MEDICAL BRANCH GALVESTON · Hospital · CCN 450018
- Inpatient rehabilitation facility — CCN 673061
Group affiliation since 2019
Membership spans across every group on this clinician's 2019+ registry record, departed groups included. Membership spans only — no volume is attributed to any group here.
Provider overview · all codes · CY2024
The full analytics for this provider
PremiumThe full billed-volume analytics for this provider — its position among specialty peers, practice focus, and the payments behind it — computed from the same disclosed Medicare Part B data.
- Charge, service & beneficiary totals — the disclosed scale, all codes
- Practice profile — focus & reach — top codes by share of services
- Office vs. facility setting mix — place-of-service code split
- Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
- Peer positioning — code breadth — how many codes billed, vs peers
Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.
Notify me at launch → Or see a live example profile →Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Volume locked column | Beneficiary-episodes locked column | Avg charge locked column | Avg Medicare payment locked column |
|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 94726 | Test to determine lung volumes using sensors | premium | premium | premium | premium |
| 94729 | Test to examine how well the lungs exchange gases | premium | premium | premium | premium |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | premium | premium | premium | premium |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | premium | premium | premium | premium |
| 71250 | Ct scan of chest without contrast | premium | premium | premium | premium |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | premium | premium | premium | premium |
| 71046 | X-ray of chest, 2 views | premium | premium | premium | premium |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | premium | premium | premium | premium |
| 99205 | New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | premium | premium | premium | premium |
| 87486 | Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | premium | premium | premium | premium |
| 87498 | Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique | premium | premium | premium | premium |
| 87541 | Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique | premium | premium | premium | premium |
| 87581 | Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | premium | premium | premium | premium |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | premium | premium | premium | premium |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | premium | premium | premium | premium |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 94618 | Test for exercise-induced lung stress | premium | premium | premium | premium |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | premium | premium | premium | premium |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | premium | premium | premium | premium |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | premium | premium | premium | premium |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | premium | premium | premium | premium |
Showing the top 25 of 26 procedures this clinician billed. The full list is part of the premium platform. Notify me at launch →
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.